Chelmicka-Szorc E, Arnason B G
Clin Exp Immunol. 1975 Dec;22(3):539-45.
Poly-L-lysin (PLL) given subcutaneously in a dose of 3 mg/day suppresses experimental allergic encephalomyelitis in guinea-pigs. The suppressive effect of PLL can still be demonstrated when administration is begun 8 days post-immunization. The effect is disease- and species-specific since PLL (3 mg/day) does not suppress experimental allergic orchitis in guinea-pigs, nor does it suppress EAE in rats (1-5 mg/day). PLL (0-2 mg/day) does not decrease the severity of graft-versus-host disease (GVH) in mice as judged by the spleen/body weight assay.
以每日3毫克的剂量皮下注射聚-L-赖氨酸(PLL)可抑制豚鼠实验性变应性脑脊髓炎。在免疫接种后8天开始给药时,PLL的抑制作用仍可得到证实。这种作用具有疾病和物种特异性,因为PLL(每日3毫克)不能抑制豚鼠实验性变应性睾丸炎,也不能抑制大鼠的实验性变应性脑脊髓炎(每日1 - 5毫克)。通过脾/体重测定法判断,PLL(每日0 - 2毫克)不会降低小鼠移植物抗宿主病(GVH)的严重程度。